Forte Biosciences, Inc. Common Stock (FBRX) is a publicly traded Healthcare sector company. As of August 27, 2026, FBRX trades at $76.98 with a market cap of $1.63B and a P/E ratio of -16.35. FBRX moved +0.04% today. Year to date, FBRX is +226.09%; over the trailing twelve months it is +583.75%. Its 52-week range spans $4.90 to $77.20. Analyst consensus is neutral with an average price target of $76.60. Rallies surfaces FBRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Forte Biosciences, Inc. Common Stock (FBRX) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. FBRX moved +0.04% today. Analyst consensus is neutral.
| Metric | Value |
|---|---|
| Price | $76.98 |
| Market Cap | $1.63B |
| P/E Ratio |
|---|
| -16.35 |
| EPS | $-4.71 |
|---|
| Dividend Yield | 0.00% |
|---|
| 52-Week High | $77.20 |
|---|
| 52-Week Low | $4.90 |
|---|
| Volume | 1.36M |
|---|
| Avg Volume | 0 |
|---|
| Revenue (TTM) | $2.71M |
|---|
| Net Income | $-69.38M |
|---|
| Gross Margin | 0.00% |
|---|
5 analysts cover FBRX: 0 strong buy, 1 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $76.60.